BCL2 and neoplasm: Among the gene coding apoptosis and cell proliferation protein regulators, Bcl-2, an antiapopototic protein, survivin, one of the member of the inhibitor of apoptosis (IAP) protein family and p53 may identify CRC patients at a higher risk of tumor progression [12-14].